Crosstalk Between Metabolic Reprogramming and Epigenetic Modifications in Colorectal Cancer: Mechanisms and Clinical Applications
Current Issues in Molecular Biology · 12.09.2025 · 47 (9) · 751
DOI: 10.3390/cimb47090751 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Current Issues in Molecular Biology, online erschienen am 12.09.2025. Verfasst von Yu-Hui Sun und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Graduate School of Nanjing Medical University, Nanjing 210000, China. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 158 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Key Project of Changzhou Medical Center of Nanjing Medical University, Science and Technology Project of Changzhou Municipal Health Commission.
Abstract (Originalsprache)
Colorectal cancer (CRC) is one of the most common malignant tumors of the digestive tract in developing countries. It exhibits significant metabolic reprogramming and epigenetic abnormalities during its development. These two changes interact at the molecular level and jointly promote the progression of tumor cells. Cancer cells reprogram metabolites such as glucose, glutamine, and lipids to meet their energy and biological substrate requirements for survival. Concurrently, abnormalities in epigenetic modifications drive imbalances in gene expression and sustain the malignant phenotype. More importantly, metabolites can serve as substrates or cofactors for epigenetic enzymes, and changes in metabolic status can induce epigenetic remodeling. Correspondingly, epigenetic mechanisms regulate the transcription and function of metabolism-related genes, leading to adaptive alterations in tumor metabolic pathways. This review systematically summarizes the characteristics of major metabolic pathway reprogramming and the mechanisms underlying key epigenetic abnormalities in CRC. Furthermore, it elaborates on the mechanisms of their mutual influence in signaling pathways, key factors, immunometabolism, and the tumor microenvironment. It also discusses recent advances in novel diagnostic technologies (such as multi-omics integrated diagnostics) and therapeutic strategies (including targeting metabolism, epigenetic therapy, and combination therapies). In the future, research focusing on the interaction between metabolic reprogramming and epigenetics will provide new insights and targets for the early diagnosis and precision treatment of CRC.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology, Graduate School of Nanjing Medical University, Nanjing 210000, China.
- Affiliated Changzhou No. 2 People's Hospital of Nanjing Medical University, Changzhou 213161, China.
Förderung
- The Key Project of Changzhou Medical Center of Nanjing Medical University
- Science and Technology Project of Changzhou Municipal Health Commission
Zitieren
APA
Sun, Y. H., Zhang, J. X., Jin, H. S., & Huang, J. (2025). Crosstalk Between Metabolic Reprogramming and Epigenetic Modifications in Colorectal Cancer: Mechanisms and Clinical Applications. Current Issues in Molecular Biology, 47(9), 751. https://doi.org/10.3390/cimb47090751
Vancouver
Sun YH, Zhang JX, Jin HS, Huang J. Crosstalk Between Metabolic Reprogramming and Epigenetic Modifications in Colorectal Cancer: Mechanisms and Clinical Applications. Current Issues in Molecular Biology. 2025;47(9):751. doi:10.3390/cimb47090751
BibTeX
@article{Sun2025,
author = {Sun, Yu-Hui and Zhang, Jing-Xian and Jin, Han-Shu and Huang, Jin},
title = {Crosstalk Between Metabolic Reprogramming and Epigenetic Modifications in Colorectal Cancer: Mechanisms and Clinical Applications},
journal = {Current Issues in Molecular Biology},
year = {2025},
volume = {47},
number = {9},
pages = {751},
doi = {10.3390/cimb47090751}
}
EUVIMED